Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
06/2002
06/20/2002WO2002048366A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
06/20/2002WO2002048365A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
06/20/2002WO2002048364A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
06/20/2002WO2002048363A2 Human transporter proteins, nucleic acid molecules encoding them, and uses thereof
06/20/2002WO2002048362A2 Embryogenesis associated proteins
06/20/2002WO2002048361A2 Novel secreted proteins and their uses
06/20/2002WO2002048360A1 Estrogen receptor genes and utilization thereof
06/20/2002WO2002048359A1 Magnetic particle membrane-specific protein
06/20/2002WO2002048358A2 Regulation of human chemokine-like receptor
06/20/2002WO2002048357A1 A novel polypeptide, a human c0p9 compound subunit 37.62 and the polynucleotide encoding the polypeptide
06/20/2002WO2002048356A1 A novel polypeptide, a human cytochrome constitutive protein 45 and the polynucleotide encoding the polypeptide
06/20/2002WO2002048355A1 A novel polypeptide, a human garp protein 12.98 and the polynucleotide encoding the polypeptide
06/20/2002WO2002048354A1 Tumour suppressor gene identified on chromosome 18
06/20/2002WO2002048353A2 Dna-sequences, which code for an apoptosis signal transduction protein
06/20/2002WO2002048351A2 A method for in vitro molecular evolution of protein function
06/20/2002WO2002048350A1 Transformed yeast presenting cellulose-binding domain on the cell surface layer
06/20/2002WO2002048348A1 Novel gene existing in human leukocyte antigen domain
06/20/2002WO2002048347A1 Molecule correspondent to genotype and phenotype, composing elements thereof, method of producing the corespondent molecule and method of using the same
06/20/2002WO2002048346A2 Transgenic mice containing bsmap gene disruptions
06/20/2002WO2002048344A2 Gene therapy for prostate cancer: sensibilization of cells to dn a damaging drugs and radiation
06/20/2002WO2002048343A2 Transgenic mice containing adrenocorticotropin hormone receptor gene disruptions
06/20/2002WO2002048342A2 Knockout mice for trp6 gene
06/20/2002WO2002048341A2 Knockout mice for a2d2 calcium ion channel subunit proteins
06/20/2002WO2002048340A2 Transgenci mice containing cashgene disruptions
06/20/2002WO2002048339A2 Transgenic mice containing kir5.1 inwardly rectifying potassium channel gene disruptions
06/20/2002WO2002048338A2 Yeast strain for testing the geno- and cytotoxicity of complex environmental contamination
06/20/2002WO2002048337A2 Secreted human proteins
06/20/2002WO2002048335A2 Metal resistant plants and use for phytoremediation
06/20/2002WO2002048333A2 Novel human kinases and uses thereof
06/20/2002WO2002048332A2 Recombinant phytases and uses thereof
06/20/2002WO2002048326A2 Human caplain proteins and polynucleotides coding therefor
06/20/2002WO2002048325A2 Regulation of human serine palmitoyltransferase
06/20/2002WO2002048322A2 Recombinant porcine liver esterases, their use and a method for the production thereof
06/20/2002WO2002048321A2 Use of acetyl-coa carboxylase for identifying compounds that have an insecticidal effect
06/20/2002WO2002048314A2 Antisense modulation of raidd expression
06/20/2002WO2002048313A2 Senescence-associated plant promotors
06/20/2002WO2002048195A2 Engineered stimulus-responsive switches
06/20/2002WO2002048194A1 Fusion protein having the enhanced in vivo activity of erythropoietin
06/20/2002WO2002048189A2 Combinatorial libraries of proteins having the scaffold structure of c-type lectin-like domains
06/20/2002WO2002048187A2 Secretion signal peptides, their dna sequences, expression vectors for eukaryotic cells that can be produced with the same, and use thereof for biotechnological production of proteins
06/20/2002WO2002048186A1 A novel polypeptide-homo insulinoid growth factor conjugated protein 10.45 and polynucleotide encoding said polypeptide
06/20/2002WO2002048182A2 Interferon-alpha induced gene
06/20/2002WO2002048170A1 Lipids comprising an aminoxy group
06/20/2002WO2002048168A1 Antisense modulation of tnfr1 expression
06/20/2002WO2002048167A1 Method for generating immortal dendritic cell lines
06/20/2002WO2002048164A2 Isolation of nucleic acids
06/20/2002WO2002047721A1 Silensed anti-cd28 antibodies and use thereof
06/20/2002WO2002047718A2 Methods and compositions for vaccination comprising nucleic acid ad/or polypeptide sequences of $i(chlamydia)
06/20/2002WO2002047717A2 Targeted enzyme prodrug therapy
06/20/2002WO2002047610A2 Marine actinomycete taxon for drug and fermentation product dicovery
06/20/2002WO2002047534A2 Compositions and methods for the therapy and diagnosis of lung cancer
06/20/2002WO2002047479A2 Cloning bovines by nuclear transplantation
06/20/2002WO2002047478A2 Transgenic mice containing proliferator-activated receptor gene disruptions
06/20/2002WO2002047477A2 Transgenic mice containing huntingtin interacting protein 1 gene disruptions
06/20/2002WO2002047476A2 Transgenic mice containing serine/threonine kinase (stk) target gene disruptions
06/20/2002WO2002047475A1 Method of efficiently constructing transgenic birds and transgenic birds thus obtained
06/20/2002WO2002047474A1 Transgenic animal expressing hla-a24 and utilization thereof
06/20/2002WO2002047466A2 Beta-secretase transgenic organisms, anti-beta-secretase antibodies, and methods of use thereof
06/20/2002WO2002042475A8 Gene hd3a inducing flowering of plant and utilization thereof
06/20/2002WO2002040518A8 Periplasmic domain of an enterobacterium omp protein and its use as carrier or adjuvant
06/20/2002WO2002034894A3 Plant promoter providing high levels of gene expression in fruits
06/20/2002WO2002031202A3 High throughput genetic screening of lipid and cholesterol processing using fluorescent compounds
06/20/2002WO2002031110A3 Hematopoietic stem cell gene therapy
06/20/2002WO2002028905A3 Human anti-cd40 antibodies
06/20/2002WO2002028406A3 Induction of blood vessel formation by polynucleotides encoding sphingosine kinases
06/20/2002WO2002027001A3 Plants with masked fertility
06/20/2002WO2002026755A3 Nucleotide sequences which code for the ppgk gene
06/20/2002WO2002020738A3 27877, a phospholipase and uses therefor
06/20/2002WO2002020730A3 Manganese lipoxygenase
06/20/2002WO2002018426A3 Rabbit hemorrhagic disease vaccine and antigens
06/20/2002WO2002016436A3 ANTIBODIES TO HUMAN IL-1$g(b)
06/20/2002WO2002014474A3 Method of treating alzheimer's disease with cell therapy
06/20/2002WO2002012334A3 Snake venom polypeptide zsnk1
06/20/2002WO2002010415A3 Methods for the controlled, automatic excision of heterologous dna from transgenic plants and dna-excising gene cassettes for use therein
06/20/2002WO2002008866A3 Spread spectrum meter reading system utilizing low-speed/high-power frequency hopping
06/20/2002WO2002008393A3 Serine protease from yersinia enterocolitica
06/20/2002WO2002008291A3 Multi-specific reagent for selective stimulation of cell surface receptors
06/20/2002WO2002007763A3 Helicobacter pylori with modified lipopolysaccharide biosynthesis
06/20/2002WO2002004600A3 Novel compounds
06/20/2002WO2002003911A8 Prevention and treatment of alzheimer's disease
06/20/2002WO2002000711A3 Ev-vegf nucleic acids and polypeptides and methods of use
06/20/2002WO2001095933A3 Immunization through oral administration of a vaccine with an edible product
06/20/2002WO2001094574A3 Method and apparatus for purifying nucleic acids
06/20/2002WO2001094393A3 Synthetic spider silk proteins and the expression thereof in transgenic plants
06/20/2002WO2001092876A3 Method for identifying compounds for modulating the activity of a tumour suppressor protein
06/20/2002WO2001092504A3 Triacylglycerol lipases from arabidopsis thaliana
06/20/2002WO2001090386A3 Gene regulatory region that promotes early seed-specific transcription
06/20/2002WO2001090194A3 Antibodies against particular forms of propsa and use thereof in immunoassays
06/20/2002WO2001090191A3 ANTIBODIES CAPABLE TO SELECTIVELY DETECT PRION PrPSc ISOFORMS
06/20/2002WO2001090152A3 Compositions and methods for the therapy and diagnosis of breast cancer
06/20/2002WO2001090139A3 A ligand for enhancing oral and cns delivery of biological agents
06/20/2002WO2001088114A3 Gene expression system
06/20/2002WO2001088104A3 Neural progenitor cell populations
06/20/2002WO2001087977A3 Methods and compositions of matter concerning april/g70, bcma, blys/agp-3, and taci
06/20/2002WO2001085959A3 Regulation of human lysostaphin-like protease
06/20/2002WO2001085950A3 Genes of the 1-desoxy-d-xylulose biosynthesis path
06/20/2002WO2001085942A3 Cytoskeleton-associated proteins
06/20/2002WO2001085941A3 Myc targets
06/20/2002WO2001085096A3 Mast cell regulation
06/20/2002WO2001083793A3 Targeted modification of chromatin structure
1 ... 2781 2782 2783 2784 2785 2786 2787 2788 2789 2790 2791 2792 2793 2794 2795 2796 2797 2798 2799 2800 2801 ... 4023